Liver Vitality

Abstract

This disclosure relates to administering, manufacturing, and composing oral formulations to treat and prevent fatty liver disease, liver dysfunction, and hepatic impairment. The treatment and prevention may be one or both liver dysfunction-related primary and secondary diseases. The herbal blend may be made of one or more artichokes, dandelion, milk thistle, alpha-lipoic acid, and turmeric. The enzyme blend may be made of one or more isolated enzymes from amylase, glucoamylase, protease 4.5, protease 6, protease 3, neutral protease, peptidase, papain, alpha-galactosidase, acid maltase, cellulase, pectinase, protease inhibitor 6.0, lipase, lactase, bromelain, cellulase, xylanase, beta-glucanase, invertase, hemicellulose, etc., and any combination thereof. The formulation may be in two compartments, the outer and the inner—the outer compartment has the herbal blend and the internal has the enzyme blend. The inner compartment may be gastric acid resistant.

Dependencies are inferred from the claim text.